FDA advisory committee votes in favor of investigational anti-epileptic drug ezogabine
Links shared publicly online about this topic.
- 953total visits
FDA advisory committee votes in favor of investigational anti-epileptic drug ezogabine
View full resource at news-medical.net
Tags: Seizure, Epilepsy, Drug, FDA, GlaxoSmithKline, Epilepsy Medication, News
Most Recently Shared on August 12, 2010 at 10:48 am By:
Epilepsy News: FDA advisory committee votes in favor of investigational anti-epileptic drug ezogabine: GlaxoSmithK... http://bit.ly/bDPd5k
Investigational Anti-Epileptic Drug Moves Through FDA Advisory Committee on ADVANCE for Nurses
nursing.advanceweb.com — “An FDA advisory committee voted unanimously that clinical studies had provided substantial evidence of the effectiveness of ezogabine as adjunctive treatment for adults with partial-onset seizures.” View full resource at nursing.advanceweb.com
Most Recently Shared on August 26, 2010 at 3:25 pm By:
Sanitasole Senior Health Business
Investigational Anti-Epileptic Drug Moves Through FDA Advisory Committee http://tinyurl.com/2adzv2q #health #wellness #epilepsy
Ezogabine, An Investigational Anti-Epileptic Drug, Receives Positive Vote From FDA Advisory Committee - QualityPoint Technologies
qualitypointtech.net — “GlaxoSmithKline (NYSE: GSK) and Valeant Pharmaceuticals International (NYSE: VRX) announced that a U.S. Food and Drug Administration (FDA) advisory committee voted unanimously that clinical studies had provided substantial evidence of the effectiveness of ezogabine as adjunctive treatment for adults with partial-onset seizures. After a review of the safety data, including urinary retention, infection and kidney stones, the majority of Committee members voted that urinary retention could be mitig” View full resource at qualitypointtech.net
Most Recently Shared on August 12, 2010 at 1:45 pm By:
Ezogabine, An Investigational Anti-Epileptic Drug, Receives Positive Vote From FDA Advisory Committee: GlaxoSmithK... http://bit.ly/cCPMNX
Ezogabine, An Investigational Anti-Epileptic Drug, Receives Positive Vote From FDA Advisory Committee
medicalnewstoday.com — “GlaxoSmithKline (NYSE: GSK) and Valeant Pharmaceuticals International (NYSE: VRX) announced that a U.S. Food and Drug Administration (FDA) advisory committee voted unanimously that clinical stud” View full resource at medicalnewstoday.com
Most Recently Shared on August 12, 2010 at 12:37 pm By:
Ezogabine, An Investigational Anti-Epileptic Drug, Receives Positive Vote From FDA Advisory Committee GlaxoSmithKline (.. http://dld.bz/r4Mx
Advertisement
